Showing results (411-420 of 550) with videos related to

Sort By:
Pageof 55
Science Translational Medicine|December 7, 2021
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2-experienced individualsMarie I Samanovic, Amber R Cornelius, Sophie L Gray-Gaillard, et al.
Endocrine Connections|September 14, 2017
Investigating the association of rs2910164 with cancer predisposition in an Irish cohortT P McVeigh, R J Mulligan, U M McVeigh, et al.
Medrxiv : the Preprint Server for Health Sciences|February 17, 2021
Robust immune responses after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individualsMarie I Samanovic, Amber R Cornelius, Sophie L Gray-Gaillard, et al.
Open Forum Infectious Diseases|August 2, 2017
Biphasic Zika Illness With Rash and Joint PainSrilatha Edupuganti, Muktha S Natrajan, Nadine Rouphael, et al.
Nature Protocols|October 13, 2023
Generation of quality-controlled SARS-CoV-2 variant stocksMaren de Vries, Grace O Ciabattoni, Bruno A Rodriguez-Rodriguez, et al.
Proceedings. Biological Sciences|July 30, 2010
Ancient DNA from Nubian and Somali wild ass provides insights into donkey ancestry and domesticationBirgitta Kimura, Fiona B Marshall, Shanyuan Chen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
Cross-reactive CD8+ T cell epitopes identified in US adolescent minoritiesSteffanie Sabbaj, Anju Bansal, G Douglas Ritter, et al.
Open Forum Infectious Diseases|November 1, 2019
Occupational Exposure to the Ugandan Research Strain (MR766) of Zika VirusPaola N Lichtenberger, Michael J Ricciardi, Dalhila Solorzano, et al.
JAMA|October 8, 2014
Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trialMark J Mulligan, David I Bernstein, Patricia Winokur, et al.
Vaccine|December 28, 2017
Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccineLisa A Jackson, Hana M El Sahly, Sarah George, et al.
Pageof 55